| Dr Sabina Villalobos Correa, PSYD | |
|
2100 Napa Vallejo Hwy., Napa, CA 94558-6293 | |
| (707) 253-5000 | |
| Not Available |
| Full Name | Dr Sabina Villalobos Correa |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 2100 Napa Vallejo Hwy., Napa, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083983803 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 28144 (California) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sabina Villalobos Correa, PSYD 2100 Napa Vallejo Hwy., Napa, CA 94558-6293 Ph: (707) 253-5000 | Dr Sabina Villalobos Correa, PSYD 2100 Napa Vallejo Hwy., Napa, CA 94558-6293 Ph: (707) 253-5000 |
News Archive
Humans, followed by ferrets and to a lesser extent cats, civets and dogs are the most susceptible animals to SARS-CoV-2 infection, according to an analysis of ten different species carried out by researchers at the Centre for Genomic Regulation (CRG), based in Barcelona.
EarlySense, which is currently bringing to market the most advanced, contact-free, patient monitoring solution for hospitals and nursing homes, announced today that it has received FDA clearance and CE approval for the new wireless (WiFi) communications component of its solution.
AB Science SA, a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), announces today that data from the development program of masitinib in gastrointestinal stromal tumors (GIST) have been presented as part of three presentations delivered at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting, 1-5 June in Chicago, Illinois.
In a six-week study in adolescents (13-17 years old) with schizophrenia, the Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company atypical antipsychotic aripiprazole demonstrated significant improvement compared to placebo on the primary efficacy endpoint, Positive and Negative Syndrome Scale (PANSS) Total Score.
› Verified 2 days ago
Dr. Steven Jin Choi, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2100 Napa Vallejo Hwy, Napa, CA 94558 Phone: 707-254-2712 Fax: 707-253-5097 | |
Mr. Benjamin Joseph Levin, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2100 Napa Vallejo Hwy, Napa, CA 94558 Phone: 707-253-5631 | |
Joan Dittrich, PH D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1141 Division St, Napa, CA 94559 Phone: 707-258-1426 | |
Brittany Alyce Cunningham, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2100 Napa Vallejo Hwy, Napa, CA 94558 Phone: 707-253-5654 | |
Dr. Michael Kelley, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 553 Jefferson St, Napa, CA 94559 Phone: 707-337-0470 | |
Dr. Kristopher M Thomas, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2100 Napa Vallejo Hwy, Napa, CA 94558 Phone: 707-253-5460 | |
Dr. Jo Gilbert, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1303 Jefferson St, Ste. 600a, Napa, CA 94559 Phone: 707-224-2893 Fax: 707-224-2894 |